反制欧盟，财政部发文限制进口欧盟部分仪器设备

Core Viewpoint - The European Union has implemented restrictions on Chinese companies participating in public procurement for medical devices valued over 5 million euros, prompting China to respond with reciprocal measures to protect its domestic market and companies [1][4]. Group 1: EU Restrictions - On June 20, the EU Commission announced limitations on Chinese enterprises in medical device tenders exceeding 5 million euros under the International Procurement Instrument (IPI) [1]. - The EU's decision is seen as a public procurement barrier against Chinese companies, leading to China's countermeasures aimed at ensuring fair competition [1][4]. Group 2: China's Response - Starting from July 6, 2025, if a procurement project requires medical devices with a budget of 45 million RMB or more, EU companies (excluding European capital companies established in China) will be excluded from bidding unless no alternatives are available [3]. - Non-EU companies participating in tenders can only have 50% of their contract value sourced from EU medical devices, promoting diversity in government procurement and reducing reliance on the Chinese market [3]. Group 3: Exceptions and Implications - The restrictions do not apply if the procurement can only be fulfilled by EU-manufactured medical devices, allowing for continued procurement in specific cases [4]. - The measures primarily affect directly imported medical devices from the EU, while those produced by European companies within China are exempt, indicating a protective stance towards the domestic market while supporting foreign enterprises operating in China [4]. - Notable EU medical device manufacturers like Siemens Healthineers and Philips Healthcare may face business impacts in the Chinese market, while local Chinese companies could see growth opportunities [4].